| No. |
Date |
Title |
Institution(s) |
| |
3/10/2021 |
Nano-micelle Packaging CRISPR/Cas9 Components Enables Brain Genome Editing |
iCONM, Kyoto Prefectural University of Medicine |
| |
2/22/2021 |
Identification of a novel potent therapeutic strategy that the targeting of long non-coding RNA for the treatment of lethal pancreatic ductal adenocarcinoma. |
Nagoya University , Nagoya City University , AMED , University of Tokyo , iCONM , Japanese Foundation for Cancer Research |
| |
2/18/2021 |
Nanomedicine Activation Profile Determines Efficacy Depending on Tumor c-Myc Expression |
iCONM,University of Tokyo Graduate School |
| |
1/19/2021 |
The ultra-small nanomedicines which can stably deliveroligonucleotides in the bloodstream for thetherapyof refractory cancers. |
iCONM,University of Tokyo Graduate School |
| |
11/25/2020 |
A new website for the essence of COINS～in-body hospitalsâ changes the future～ |
iCONM |
| |
11/12/2020 |
A Therapeutic Option for Glioblastoma using pH-Sensitive Nanomicelles |
iCONM |
| |
11/4/2020 |
The 7th COINS Symposium “Future Medicine is Comin' to Town” |
iCONM |
| |
9/28/2020 |
"Innovation Japan 2020 -University Trade Shows Online" information of exhibition ～In-body hospitals® changes the future～ |
iCONM |
| |
9/3/2020 |
Start of an investigator initiated clinical trial (First In Human study) with a nano-medicine with siRNA targeting PRDM14 for the treatment of breast cancer patients. |
iCONM, Cancer Institute Hospital, Medical Science – the University of Tokyo,Sapporo Medical University, Keio University Hospital, NanoCarrier Co., Ltd., Japan Agency for Medical Research and Development |
| |
8/4/2020 |
Epirubicin-Loaded Nanomedicines Beat Immune Checkpoint
Blockade Resistance in Glioblastoma |
iCONM, University of Tokyo |
| |
7/27/2020 |
Developing a new strategy to selectively deliver therapies to the brain
Turning the problem into the solution: exploiting the impermeability
of the brain vasculature to target nano-vehicles to the brain |
iCONM, University of Tokyo |
| |
6/26/2020 |
Development of a safe liver sinusoidal wall coating agent to significantly increase the efficacy of gene therapy drugs
Controlling the clearance of gene therapy drugs at the liver sinusoidal wall |
iCONM, National Institutes for Quantum and Radiological Science and Technology, University of Toky |
| |
6/4/2020 |
Research and development focus on producing technology of the mRNA vaccine in preparation for the re-emergence of Covid-19 and / or further mutated species of “coronavirus” -Tokyo Metropolitan Institute of Medical Science and iCONM start collaborative research- |
iCONM、Tokyo Metropolitan Institute of Medical Science |
| |
5/20/2020 |
Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain |
iCONM, University of Tokyo, Tokyo Medical and Dental University |
| |
5/12/2020 |
Treat expectant mother while protecting baby with covering the medicine with nanocapsules. |
iCONM, KISTEC, The University of Tokyo |
| |
4/2/2020 |
A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application |
iCONM、The University of Tokyo |
